Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment
- PMID: 9294405
- DOI: 10.1006/exnr.1997.6592
Myelination following transplantation of EGF-responsive neural stem cells into a myelin-deficient environment
Abstract
Epidermal growth factor (EGF)-responsive stem cells have been identified in the murine central nervous system. These cells can be isolated from the brain and maintained in an undifferentiated state in vitro in the presence of EGF. After removing EGF, the cells cease mitosis and can be induced to differentiate into neurons, astrocytes, and oligodendrocytes. We demonstrate that when the undifferentiated stem cells (nestin-positive) are injected into the myelin-deficient rat spinal cord, they respond to cues within the mutant CNS and differentiate into myelinating oligodendrocytes, in contrast to their behavior in vitro, where they mainly form astrocytes. The cells provide a valuable model system for the study of the development of early oligodendrocytes from multipotent neural stem cells. Because these cells are influenced to divide using growth factors, rather than oncogenes, and because they appear to make appropriate lineage decisions when transplanted into a mutant environment, they may provide an excellent source of cells for a variety of future therapies using cellular transplantation.
Similar articles
-
Generation and transplantation of EGF-responsive neural stem cells derived from GFAP-hNGF transgenic mice.Exp Neurol. 1997 Nov;148(1):187-204. doi: 10.1006/exnr.1997.6657. Exp Neurol. 1997. PMID: 9398461
-
Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination.Exp Neurol. 2008 Sep;213(1):176-90. doi: 10.1016/j.expneurol.2008.05.024. Epub 2008 Jun 10. Exp Neurol. 2008. PMID: 18586031
-
Lines of glial precursor cells immortalised with a temperature-sensitive oncogene give rise to astrocytes and oligodendrocytes following transplantation into demyelinated lesions in the central nervous system.Glia. 1993 Sep;9(1):25-40. doi: 10.1002/glia.440090105. Glia. 1993. PMID: 8244529
-
From neural stem cells to myelinating oligodendrocytes.Mol Cell Neurosci. 1999 Oct-Nov;14(4-5):287-300. doi: 10.1006/mcne.1999.0790. Mol Cell Neurosci. 1999. PMID: 10588385 Review.
-
Neural precursors and demyelinating diseases.Prog Brain Res. 2001;132:175-84. doi: 10.1016/S0079-6123(01)32074-5. Prog Brain Res. 2001. PMID: 11544986 Review. No abstract available.
Cited by
-
Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.Neurosurg Rev. 2012 Jul;35(3):293-311; discussion 311. doi: 10.1007/s10143-012-0385-2. Epub 2012 Apr 27. Neurosurg Rev. 2012. PMID: 22539011 Review.
-
Polysialylated neural cell adhesion molecule-positive CNS precursors generate both oligodendrocytes and Schwann cells to remyelinate the CNS after transplantation.J Neurosci. 1999 Sep 1;19(17):7529-36. doi: 10.1523/JNEUROSCI.19-17-07529.1999. J Neurosci. 1999. PMID: 10460259 Free PMC article.
-
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins.J Neuroinflammation. 2007 Dec 18;4:30. doi: 10.1186/1742-2094-4-30. J Neuroinflammation. 2007. PMID: 18088439 Free PMC article.
-
Novel cellular approaches to repair of neurodegenerative disease: from Sertoli cells to umbilical cord blood stem cells.Neurotox Res. 2002 Mar;4(2):95-101. doi: 10.1080/10298420290015917. Neurotox Res. 2002. PMID: 12829408
-
PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.PLoS One. 2013;8(2):e55149. doi: 10.1371/journal.pone.0055149. Epub 2013 Feb 1. PLoS One. 2013. PMID: 23383310 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical